The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy.
cancer immunotherapy
immune checkpoints
immune monitoring
programmed cell death 1 ligand 1
programmed cell death protein 1
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Sep 2019
25 Sep 2019
Historique:
received:
03
09
2019
revised:
17
09
2019
accepted:
24
09
2019
entrez:
28
9
2019
pubmed:
29
9
2019
medline:
29
9
2019
Statut:
epublish
Résumé
The administration of antibodies blocking the immune checkpoint molecules programmed cell death protein 1 (PD-1) or programmed cell death 1 ligand 1 (PD-L1) has evolved as a very promising treatment option for cancer patients. PD-1/PD-L1 inhibition has significantly enhanced expansion, cytokine secretion, and cytotoxic activity of CD4
Identifiants
pubmed: 31557787
pii: jcm8101534
doi: 10.3390/jcm8101534
pmc: PMC6832659
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Immunity. 1999 Oct;11(4):423-32
pubmed: 10549624
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
N Engl J Med. 2018 Nov 29;379(22):2108-2121
pubmed: 30345906
Cancer Discov. 2017 Dec;7(12):1420-1435
pubmed: 29025772
Science. 2018 Feb 16;359(6377):801-806
pubmed: 29301960
Cell. 2017 Nov 2;171(4):934-949.e16
pubmed: 29033130
Nat Rev Cancer. 2016 May;16(5):275-87
pubmed: 27079802
Histopathology. 2018 Feb;72(3):449-459
pubmed: 28851100
Clin Cancer Res. 2016 Apr 15;22(8):1865-74
pubmed: 27084740
Cancer Discov. 2018 Jul;8(7):822-835
pubmed: 29773717
Science. 2015 Apr 3;348(6230):124-8
pubmed: 25765070
Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
Nat Commun. 2017 Oct 26;8(1):1136
pubmed: 29070816
J Clin Oncol. 2016 Sep 10;34(26):3119-25
pubmed: 27269937
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Lancet Oncol. 2018 Jul;19(7):e341
pubmed: 29887223
Clin Cancer Res. 2016 Nov 15;22(22):5487-5496
pubmed: 27185375
Science. 2018 Mar 23;359(6382):1366-1370
pubmed: 29567708
Eur J Cancer. 2019 Jan;106:234-243
pubmed: 30528808
Lancet Oncol. 2017 Mar;18(3):312-322
pubmed: 28131785
J Exp Med. 2006 Apr 17;203(4):883-95
pubmed: 16606670
N Engl J Med. 2018 Nov 22;379(21):2040-2051
pubmed: 30280635
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Oncoimmunology. 2019 Feb 18;8(4):e1568812
pubmed: 30906663
Cell. 2017 Sep 7;170(6):1120-1133.e17
pubmed: 28803728
Sci Transl Med. 2012 Mar 28;4(127):127ra37
pubmed: 22461641
J Clin Oncol. 2015 Jun 10;33(17):1974-82
pubmed: 25605845
J Immunother Cancer. 2018 Jan 23;6(1):8
pubmed: 29357948
Clin Cancer Res. 2007 Apr 1;13(7):2151-7
pubmed: 17404099
Lancet. 2019 Jun 15;393(10189):2404-2415
pubmed: 31079938
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
Front Med (Lausanne). 2019 May 22;6:113
pubmed: 31192212
N Engl J Med. 2015 Jan 22;372(4):320-30
pubmed: 25399552
Cancer Immunol Res. 2016 Mar;4(3):194-203
pubmed: 26787823
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
J Clin Oncol. 2014 Apr 1;32(10):1020-30
pubmed: 24590637
Nat Med. 2018 Feb;24(2):144-153
pubmed: 29309059
J Clin Oncol. 2015 Jun 20;33(18):2004-12
pubmed: 25897158
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
Nature. 2018 Aug;560(7718):382-386
pubmed: 30089911
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
JAMA Netw Open. 2019 Jul 3;2(7):e197621
pubmed: 31339548
N Engl J Med. 2018 Apr 05;378(14):1277-1290
pubmed: 29562145
N Engl J Med. 2015 May 21;372(21):2018-28
pubmed: 25891174
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Blood. 2010 Aug 26;116(8):1291-8
pubmed: 20472828
Nat Rev Clin Oncol. 2017 Nov;14(11):655-668
pubmed: 28653677
Nat Med. 2018 Sep;24(9):1441-1448
pubmed: 30082870
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
Annu Rev Immunol. 2016 May 20;34:539-73
pubmed: 26927206
Science. 2016 Mar 25;351(6280):1463-9
pubmed: 26940869
JAMA Oncol. 2017 Aug 1;3(8):1051-1058
pubmed: 28278348
Nature. 2017 Nov 23;551(7681):517-520
pubmed: 29132144
J Clin Oncol. 2015 May 1;33(13):1430-7
pubmed: 25452452
Nat Immunol. 2019 Sep;20(9):1231-1243
pubmed: 31358999
Immunity. 2019 Jun 18;50(6):1498-1512.e5
pubmed: 31097342
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
Nature. 2018 Jan 18;553(7688):347-350
pubmed: 29320474
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Nat Med. 2018 Jul;24(7):994-1004
pubmed: 29892065
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Virchows Arch. 2019 Nov;475(5):599-608
pubmed: 31267201
Nature. 2017 May 4;545(7652):60-65
pubmed: 28397821
JAMA Oncol. 2019 Jul 25;:null
pubmed: 31343665
Oncoimmunology. 2014 Dec 21;3(11):e963413
pubmed: 25914862
Mod Pathol. 2016 Oct;29(10):1165-72
pubmed: 27389313
Nat Immunol. 2009 Nov;10(11):1185-92
pubmed: 19783989
Int Immunol. 2018 Feb 3;30(1):13-22
pubmed: 29294043
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
J Clin Oncol. 2009 Dec 10;27(35):5944-51
pubmed: 19858404
J Immunother Cancer. 2016 Mar 15;4:15
pubmed: 26981245
Nat Med. 1999 Dec;5(12):1365-9
pubmed: 10581077
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407
Immunity. 2016 Jun 21;44(6):1255-69
pubmed: 27332730
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
Nat Med. 2018 Jun;24(6):749-757
pubmed: 29867230
Nat Immunol. 2001 Mar;2(3):261-8
pubmed: 11224527
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
N Engl J Med. 2016 Sep 1;375(9):819-29
pubmed: 27433843
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Science. 2018 Feb 2;359(6375):582-587
pubmed: 29217585
N Engl J Med. 2013 Jul 11;369(2):134-44
pubmed: 23724846
Cancer Cell. 2018 Jun 11;33(6):1017-1032.e7
pubmed: 29894689
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4993-4998
pubmed: 28446615
N Engl J Med. 2015 Jan 22;372(4):311-9
pubmed: 25482239
FASEB J. 2018 Mar;32(3):1537-1549
pubmed: 29146734
J Clin Oncol. 2010 Jul 1;28(19):3167-75
pubmed: 20516446
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373
Nat Rev Drug Discov. 2019 Mar;18(3):175-196
pubmed: 30622344